5.27
1.74%
0.09
Handel nachbörslich:
5.22
-0.05
-0.95%
Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Research and Development |
43.86%
6.1835
|
4.2983 | 6.9617 | 6.9629 | 11.24 |
Interest Income/Expense |
3.06%
0.4985
|
0.5143 | 0.5387 | 0.5271 | 0.4913 |
Operating Income/Loss |
54.05%
-9.3939
|
-6.0978 | -9.5504 | -10.34 | -16.80 |
Nonoperating Income/Loss |
2.46%
1.3117
|
1.3448 | 1.3635 | 1.3557 | 1.1876 |
Income/Loss From Continuing Operations Before Tax |
70.04%
-8.0821
|
-4.753 | -8.1869 | -8.987 | -15.62 |
Income/Loss From Continuing Operations After Tax |
70.04%
-8.0821
|
-4.753 | -8.1869 | -8.987 | -15.62 |
Net Income/Loss
|
70.04%
-8.0821
|
-4.753 | -8.1869 | -8.987 | -15.62 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
70,151%
59.41
|
0.0846 | 58.99 | 58.79 | 58.79 |
Diluted Average Shares |
70,151%
59.41
|
0.0846 | 58.99 | 58.79 | 58.79 |
Basic Earnings Per Share |
75.00%
-0.14
|
-0.08 | -0.14 | -0.15 | -0.27 |
Diluted Earnings Per Share |
75.00%
-0.14
|
-0.08 | -0.14 | -0.15 | 0.27 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):